CWmike writes: "Red Hat used to be in the desktop business along with all the other Linux distributors. Then, they left. Now, however, Red Hat is switching from Xen to KVM for virtualization. As part of that switchover, Red Hat will be using not only KVM, but the SolidICE/SPICE desktop virtualization and management software suite to introduce a new server-based desktop virtualization system. Does this mean that Red Hat will be getting back into the Linux desktop business? That's the question I posed to Red Hat CTO Brian Stevens, in a phone call after the Red Hat/KVM press conference, and he told me that, 'Yes. Red Hat will indeed be pushing the Linux desktop again.'"
ardent99 writes: A new study (a meta-study?) shows that most of the past studies about the effectiveness of treating colds with zinc are severely flawed. The article finds that despite 20 years of research, the benefits of zinc lozenges as a therapy for the common cold have not been proven. A new study, published in the Sept. 1 issue of Clinical Infectious Diseases, currently available online, reviews the 14 placebo-controlled studies from the past two decades and finds significant fault with 10 of the studies. Of the four remaining studies, three reported no therapeutic effect from zinc lozenge or nasal spray, and one study reported positive results from zinc nasal gel.